1 |
Study of central exclusive [Image: see text] production in proton-proton collisions at [Formula: see text] and 13TeV
|
|
|
|
In: Eur Phys J C Part Fields (2020)
|
|
BASE
|
|
Show details
|
|
2 |
Initial assessment of the early arthritis for psoriatic patients diagnostic questionnaire in dermatology clinics in Australia, Korea and China.
|
|
|
|
BASE
|
|
Show details
|
|
3 |
Emotion words modulate early conflict processing in a flanker task: Differentiating emotion-label words and emotion-laden words in second language
|
|
|
|
In: Zhang, J., Teo, T. <https://researchrepository.murdoch.edu.au/view/author/Teo, Timothy.html>orcid:0000-0002-7552-8497 and Wu, C. (2018) Emotion words modulate early conflict processing in a flanker task: Differentiating emotion-label words and emotion-laden words in second language. Language and Speech, 62 (4). pp. 641-651. (2018)
|
|
BASE
|
|
Show details
|
|
4 |
The Impact of Formative Assessment on Young English Learners’ Motivation and Achievement in China
|
|
Zhang, J. - : University of Sheffield, 2018
|
|
BASE
|
|
Show details
|
|
5 |
Search for dark matter produced in association with heavy-flavor quark pairs in proton-proton collisions at [Formula: see text]
|
|
|
|
BASE
|
|
Show details
|
|
6 |
Cortical Thickness of Native Tibetans in the Qinghai-Tibetan Plateau
|
|
|
|
In: AJNR Am J Neuroradiol (2017)
|
|
BASE
|
|
Show details
|
|
7 |
Characteristics of Pro-c Analogies and Blends between Research Publications
|
|
|
|
BASE
|
|
Show details
|
|
8 |
Do Easterners and Westerners treat contradiction differently?
|
|
|
|
In: ISSN: 1567-7095 ; EISSN: 1568-5373 ; Journal of Cognition and Culture ; https://hal.archives-ouvertes.fr/hal-01400642 ; Journal of Cognition and Culture, Brill Academic Publishers, 2015 (2015)
|
|
BASE
|
|
Show details
|
|
9 |
La preposición en español y en chino. Diferencias conservadoras aditivas
|
|
|
|
BASE
|
|
Show details
|
|
10 |
Measurement of the muon reconstruction performance of the ATLAS detector using 2011 and 2012 LHC proton-proton collision data.
|
|
|
|
In: Symplectic Elements at Oxford ; Europe PubMed Central ; PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) ; Web of Science (Lite) (http://apps.webofknowledge.com/summary.do) ; Scopus (http://www.scopus.com/home.url) ; CrossRef (2014)
|
|
BASE
|
|
Show details
|
|
11 |
Lexical richness and accommodation in oral English examinations with Chinese examiners
|
|
|
|
BASE
|
|
Show details
|
|
15 |
Basal insulin and cardiovascular and other outcomes in dysglycemia.
|
|
|
|
In: New England Journal of Medicine, vol. 367, no. 4, pp. 319-328 (2012)
|
|
BASE
|
|
Show details
|
|
16 |
n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.
|
|
Bosch, J.; Gerstein, H.C.; Dagenais, G.R.; Díaz, R.; Dyal, L.; Jung, H.; Maggiono, A.P.; Probstfield, J.; Ramachandran, A.; Riddle, M.C.; Rydén, L.E.; Yusuf, S.
|
|
In: New England Journal of Medicine, vol. 367, no. 4, pp. 309-318 (2012)
|
|
Abstract:
BACKGROUND: The use of n-3 fatty acids may prevent cardiovascular events in patients with recent myocardial infarction or heart failure. Their effects in patients with (or at risk for) type 2 diabetes mellitus are unknown. METHODS: In this double-blind study with a 2-by-2 factorial design, we randomly assigned 12,536 patients who were at high risk for cardiovascular events and had impaired fasting glucose, impaired glucose tolerance, or diabetes to receive a 1-g capsule containing at least 900 mg (90% or more) of ethyl esters of n-3 fatty acids or placebo daily and to receive either insulin glargine or standard care. The primary outcome was death from cardiovascular causes. The results of the comparison between n-3 fatty acids and placebo are reported here. RESULTS: During a median follow up of 6.2 years, the incidence of the primary outcome was not significantly decreased among patients receiving n-3 fatty acids, as compared with those receiving placebo (574 patients [9.1%] vs. 581 patients [9.3%]; hazard ratio, 0.98; 95% confidence interval [CI], 0.87 to 1.10; P=0.72). The use of n-3 fatty acids also had no significant effect on the rates of major vascular events (1034 patients [16.5%] vs. 1017 patients [16.3%]; hazard ratio, 1.01; 95% CI, 0.93 to 1.10; P=0.81), death from any cause (951 [15.1%] vs. 964 [15.4%]; hazard ratio, 0.98; 95% CI, 0.89 to 1.07; P=0.63), or death from arrhythmia (288 [4.6%] vs. 259 [4.1%]; hazard ratio, 1.10; 95% CI, 0.93 to 1.30; P=0.26). Triglyceride levels were reduced by 14.5 mg per deciliter (0.16 mmol per liter) more among patients receiving n-3 fatty acids than among those receiving placebo (P<0.001), without a significant effect on other lipids. Adverse effects were similar in the two groups. CONCLUSIONS: Daily supplementation with 1 g of n-3 fatty acids did not reduce the rate of cardiovascular events in patients at high risk for cardiovascular events. (Funded by Sanofi; ORIGIN ClinicalTrials.gov number, NCT00069784.).
|
|
Keyword:
Aged; Cardiovascular Diseases/etiology; Cardiovascular Diseases/mortality; Cholesterol/blood; Combination; Diabetes Mellitus; Double-Blind Method; Drug Therapy; Fatty Acids; Female; Follow-Up Studies; Glucose Intolerance/complications; Glucose Intolerance/drug therapy; Humans; Hypoglycemic Agents/therapeutic use; Incidence; Insulin; Intention to Treat Analysis; Long-Acting/therapeutic use; Male; Middle Aged; Omega-3/therapeutic use; Proportional Hazards Models; Treatment Failure; Triglycerides/blood; Type 2/complications; Type 2/drug therapy
|
|
URL: https://doi.org/10.1056/NEJMoa1203859 https://serval.unil.ch/notice/serval:BIB_83A3987D7CC1
|
|
BASE
|
|
Hide details
|
|
17 |
Cardiorenal end points in a trial of aliskiren for type 2 diabetes.
|
|
|
|
In: New England Journal of Medicine, vol. 367, no. 23, pp. 2204-2213 (2012)
|
|
BASE
|
|
Show details
|
|
19 |
Diagnostic value of N-terminal pro-brain natriuretic peptide for pleural effusion due to heart failure: a meta-analysis
|
|
|
|
BASE
|
|
Show details
|
|
20 |
Diagnostic value of N-terminal pro-brain natriuretic peptide for pleural effusion due to heart failure: a meta-analysis
|
|
|
|
BASE
|
|
Show details
|
|
|
|